Cargando…

Nerve and Vascular Biomarkers in Skin Biopsies Differentiate Painful From Painless Peripheral Neuropathy in Type 2 Diabetes

Painful diabetic peripheral neuropathy can be intractable with a major impact, yet the underlying pain mechanisms remain uncertain. A range of neuronal and vascular biomarkers was investigated in painful diabetic peripheral neuropathy (painful-DPN) and painless-DPN and used to differentiate painful-...

Descripción completa

Detalles Bibliográficos
Autores principales: Shillo, Pallai, Yiangou, Yiangos, Donatien, Philippe, Greig, Marni, Selvarajah, Dinesh, Wilkinson, Iain D., Anand, Praveen, Tesfaye, Solomon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915761/
https://www.ncbi.nlm.nih.gov/pubmed/35295465
http://dx.doi.org/10.3389/fpain.2021.731658
_version_ 1784668118759505920
author Shillo, Pallai
Yiangou, Yiangos
Donatien, Philippe
Greig, Marni
Selvarajah, Dinesh
Wilkinson, Iain D.
Anand, Praveen
Tesfaye, Solomon
author_facet Shillo, Pallai
Yiangou, Yiangos
Donatien, Philippe
Greig, Marni
Selvarajah, Dinesh
Wilkinson, Iain D.
Anand, Praveen
Tesfaye, Solomon
author_sort Shillo, Pallai
collection PubMed
description Painful diabetic peripheral neuropathy can be intractable with a major impact, yet the underlying pain mechanisms remain uncertain. A range of neuronal and vascular biomarkers was investigated in painful diabetic peripheral neuropathy (painful-DPN) and painless-DPN and used to differentiate painful-DPN from painless-DPN. Skin biopsies were collected from 61 patients with type 2 diabetes (T2D), and 19 healthy volunteers (HV). All subjects underwent detailed clinical and neurophysiological assessments. Based on the neuropathy composite score of the lower limbs [NIS(LL)] plus seven tests, the T2D subjects were subsequently divided into three groups: painful-DPN (n = 23), painless-DPN (n = 19), and No-DPN (n = 19). All subjects underwent punch skin biopsy, and immunohistochemistry used to quantify total intraepidermal nerve fibers (IENF) with protein gene product 9.5 (PGP9.5), regenerating nerve fibers with growth-associated protein 43 (GAP43), peptidergic nerve fibers with calcitonin gene-related peptide (CGRP), and blood vessels with von Willebrand Factor (vWF). The results showed that IENF density was severely decreased (p < 0.001) in both DPN groups, with no differences for PGP9.5, GAP43, CGRP, or GAP43/PGP9.5 ratios. There was a significant increase in blood vessel (vWF) density in painless-DPN and No-DPN groups compared to the HV group, but this was markedly greater in the painful-DPN group, and significantly higher than in the painless-DPN group (p < 0.0001). The ratio of sub-epidermal nerve fiber (SENF) density of CGRP:vWF showed a significant decrease in painful-DPN vs. painless-DPN (p = 0.014). In patients with T2D with advanced DPN, increased dermal vasculature and its ratio to nociceptors may differentiate painful-DPN from painless-DPN. We hypothesized that hypoxia-induced increase of blood vessels, which secrete algogenic substances including nerve growth factor (NGF), may expose their associated nociceptor fibers to a relative excess of algogens, thus leading to painful-DPN.
format Online
Article
Text
id pubmed-8915761
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89157612022-03-15 Nerve and Vascular Biomarkers in Skin Biopsies Differentiate Painful From Painless Peripheral Neuropathy in Type 2 Diabetes Shillo, Pallai Yiangou, Yiangos Donatien, Philippe Greig, Marni Selvarajah, Dinesh Wilkinson, Iain D. Anand, Praveen Tesfaye, Solomon Front Pain Res (Lausanne) Pain Research Painful diabetic peripheral neuropathy can be intractable with a major impact, yet the underlying pain mechanisms remain uncertain. A range of neuronal and vascular biomarkers was investigated in painful diabetic peripheral neuropathy (painful-DPN) and painless-DPN and used to differentiate painful-DPN from painless-DPN. Skin biopsies were collected from 61 patients with type 2 diabetes (T2D), and 19 healthy volunteers (HV). All subjects underwent detailed clinical and neurophysiological assessments. Based on the neuropathy composite score of the lower limbs [NIS(LL)] plus seven tests, the T2D subjects were subsequently divided into three groups: painful-DPN (n = 23), painless-DPN (n = 19), and No-DPN (n = 19). All subjects underwent punch skin biopsy, and immunohistochemistry used to quantify total intraepidermal nerve fibers (IENF) with protein gene product 9.5 (PGP9.5), regenerating nerve fibers with growth-associated protein 43 (GAP43), peptidergic nerve fibers with calcitonin gene-related peptide (CGRP), and blood vessels with von Willebrand Factor (vWF). The results showed that IENF density was severely decreased (p < 0.001) in both DPN groups, with no differences for PGP9.5, GAP43, CGRP, or GAP43/PGP9.5 ratios. There was a significant increase in blood vessel (vWF) density in painless-DPN and No-DPN groups compared to the HV group, but this was markedly greater in the painful-DPN group, and significantly higher than in the painless-DPN group (p < 0.0001). The ratio of sub-epidermal nerve fiber (SENF) density of CGRP:vWF showed a significant decrease in painful-DPN vs. painless-DPN (p = 0.014). In patients with T2D with advanced DPN, increased dermal vasculature and its ratio to nociceptors may differentiate painful-DPN from painless-DPN. We hypothesized that hypoxia-induced increase of blood vessels, which secrete algogenic substances including nerve growth factor (NGF), may expose their associated nociceptor fibers to a relative excess of algogens, thus leading to painful-DPN. Frontiers Media S.A. 2021-10-22 /pmc/articles/PMC8915761/ /pubmed/35295465 http://dx.doi.org/10.3389/fpain.2021.731658 Text en Copyright © 2021 Shillo, Yiangou, Donatien, Greig, Selvarajah, Wilkinson, Anand and Tesfaye. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pain Research
Shillo, Pallai
Yiangou, Yiangos
Donatien, Philippe
Greig, Marni
Selvarajah, Dinesh
Wilkinson, Iain D.
Anand, Praveen
Tesfaye, Solomon
Nerve and Vascular Biomarkers in Skin Biopsies Differentiate Painful From Painless Peripheral Neuropathy in Type 2 Diabetes
title Nerve and Vascular Biomarkers in Skin Biopsies Differentiate Painful From Painless Peripheral Neuropathy in Type 2 Diabetes
title_full Nerve and Vascular Biomarkers in Skin Biopsies Differentiate Painful From Painless Peripheral Neuropathy in Type 2 Diabetes
title_fullStr Nerve and Vascular Biomarkers in Skin Biopsies Differentiate Painful From Painless Peripheral Neuropathy in Type 2 Diabetes
title_full_unstemmed Nerve and Vascular Biomarkers in Skin Biopsies Differentiate Painful From Painless Peripheral Neuropathy in Type 2 Diabetes
title_short Nerve and Vascular Biomarkers in Skin Biopsies Differentiate Painful From Painless Peripheral Neuropathy in Type 2 Diabetes
title_sort nerve and vascular biomarkers in skin biopsies differentiate painful from painless peripheral neuropathy in type 2 diabetes
topic Pain Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8915761/
https://www.ncbi.nlm.nih.gov/pubmed/35295465
http://dx.doi.org/10.3389/fpain.2021.731658
work_keys_str_mv AT shillopallai nerveandvascularbiomarkersinskinbiopsiesdifferentiatepainfulfrompainlessperipheralneuropathyintype2diabetes
AT yiangouyiangos nerveandvascularbiomarkersinskinbiopsiesdifferentiatepainfulfrompainlessperipheralneuropathyintype2diabetes
AT donatienphilippe nerveandvascularbiomarkersinskinbiopsiesdifferentiatepainfulfrompainlessperipheralneuropathyintype2diabetes
AT greigmarni nerveandvascularbiomarkersinskinbiopsiesdifferentiatepainfulfrompainlessperipheralneuropathyintype2diabetes
AT selvarajahdinesh nerveandvascularbiomarkersinskinbiopsiesdifferentiatepainfulfrompainlessperipheralneuropathyintype2diabetes
AT wilkinsoniaind nerveandvascularbiomarkersinskinbiopsiesdifferentiatepainfulfrompainlessperipheralneuropathyintype2diabetes
AT anandpraveen nerveandvascularbiomarkersinskinbiopsiesdifferentiatepainfulfrompainlessperipheralneuropathyintype2diabetes
AT tesfayesolomon nerveandvascularbiomarkersinskinbiopsiesdifferentiatepainfulfrompainlessperipheralneuropathyintype2diabetes